medigraphic.com

2022, Number 2

<< Back Next >>

Rev Elec Psic Izt 2022; 25 (2)

Safe injection services experiences for heroin users, a narrative review

Rodríguez KSE, Cruz CC, Fernández CC

Language: Spanish
References: 52
Page: 510-531
PDF size: 361.78 Kb.


ABSTRACT

Introduction: Safe injection facilities are harm reduction strategies, focused on the reduction of diseases, overdoses and deaths related to the injection of psychoactive substances. Aims: develop review research conducted in databases about supervised injection facilities. Results: 201 materials were obtained in the first phase, 136 articles remain after elimination of duplicates and first filter of title and abstract; finally, a content review was carried out and 55 articles were chosen to carry out the analysis. Among the articles selected, studies related to user benefits, the economic and social impact of the centers, as well as their costeffectiveness, predominate, as well as evaluations of user perception and the need or relevance of the facilities. Conclusions: safe injection facilities have been evaluated in various aspects, from monetary to sanitary, having good results, which is why they have become key elements for the implementation of harm reduction policies at different levels, as well as in prevention, emergency response and referral to treatment or various health services.


REFERENCES

  1. Bayoumi, A. M., y Zaric, G. S. (2008). The cost-effectiveness of Vancouver's supervisedinjection facility. CMAJ, 179(11), 1143-1151. https://doi.org/10.1503/cmaj.080808

  2. Bravo, M., Royuela, L., De La Fuente, L., Brugal, M., Barrio, G., Domingo-Salvany, A. yItínere Poject Group. (2009). Use of supervised injection facilities and injectionrisk behaviours among young drug injectors. Addiction, 104, 614-619.https://doi.org/10.1111/j.1360-0443.2008.02474.x

  3. Butler, G., Chapman, D., y Terry, P. (2016). Attitudes of intravenous drug users inLondon towards the provision of drug consumption rooms. Drugs: Education,Prevention and Policy, 25(1), 31-37.https://doi.org/10.1080/09687637.2016.1252316

  4. Cleirec, G., Fortias, M., Bloch, V., Clergue-Duval, V., Bellivier, F., Dusouchet, T.,Debaulieu, C., y Vorspan, F. (2018). Opinion of health professionals and drugusers before the forthcoming opening of the first drug consumption room in Paris:a quantitative cross-sectional study. Harm Reduction Journal, 15(1).https://doi.org/10.1186/s12954-018-0260-8

  5. CONADIC (2009). Norma Oficial Mexicana NOM-028-SSA2-2009 Para la prevención,tratamiento y control de las adicciones.http://www.conadic.salud.gob.mx/pdfs/norma_oficial_nom.pdf

  6. Davidson, P. J., Lopez, A. M., y Kral, A. H. (2018). Using drugs in un/safe spaces:Impact of perceived illegality on an underground supervised injecting facility inthe United States. International Journal of Drug Policy, 53, 37-44.https://doi.org/10.1016/j.drugpo.2017.12.005

  7. De Jong, W., y Weber, U. (1999). The professional acceptance of drug use: a closerlook at drug consumption rooms in the Netherlands, Germany and Switzerland.International Journal of Drug Policy, 10(2), 99–108.https://doi.org/10.1016/S0955-3959(98)00072-3

  8. DeBeck, K., Kerr, T., Bird, L., Zhang, R., Marsh, D., Tyndall, M., Montaner, J. y Wood,E. (2011). Injection drug use cessation and use of North America's first medicallysupervised safer injecting facility. Drug and alcohol dependence, 113(2-3), 172-176. DeBeck, K., Kerr, T., Bird, L., Zhang, R., Marsh, D., Tyndall, M., Montaner,J., y Wood, E. (2011). Injection drug use cessation and use of North America'sfirst medically supervised safer injecting facility. Drug and alcohol dependence,113(2-3), 172–176. https://doi.org/10.1016/j.drugalcdep.2010.07.023

  9. DeBeck, K., Kerr, T., Lai, C., Buxton, J., Montaner, J. y Wood, E. (2013). The validity ofreporting willingness to use a supervised injecting facility on subsequent programuse among people who use injection drugs. National Institute of Health, 38(1),55-62. https://doi.org/10.3109/00952990.2011.600389

  10. DeBeck, K., Wood, E., Zhang, R., Tyndall, M., Montaner, J. y Kerr, T. (2008). Police andpublic health partnerships: Evidence from the evaluation of Vancouver'ssupervised injection facility. Substance Abuse Treatment, Prevention, and Policy,3(11), 1-5. https://doi.org/10.1186/1747-597X-3-11

  11. Enns, E. A., Zaric, G. S., Strike, C. J., Jairam, J. A., Kolla, G., y Bayoumi, A. M. (2015).Potential cost-effectiveness of supervised injection facilities in Toronto andOttawa, Canada. Addiction, 111(3), 475-489. https://doi.org/10.1111/add.13195

  12. Fairbairn, N., Small, W., Van Borek, N., Wood, E., y Kerr, T. (2010). Social structuralfactors that shape assisted injecting practices among injection drug users inVancouver, Canada: a qualitative study. Harm Reduction Journal, 7(1), 20.https://doi.org/10.1186/1477-7517-7-20

  13. Fast, D., Small, W., Wood, E., y Kerr, T. (2008). The perspectives of injection drugusers regarding safer injecting education delivered through a supervised injectingfacility. Harm Reduction Journal, 5(1), 32. https://doi.org/10.1186/1477-7517-5-32

  14. Fischer, B., Rehm, J., Kim, G., y Robins, A. (2002). Safer injection facilities (SIFs) forinjection drug users (IDUs) in Canada: A review and call for an evidence-focusedpilot trial. Canadian Journal of Public Health/Revue Canadienne de SantéPublique, 93(5), 336-338.

  15. Fitzgerald, J., Burgess, M., y Snowball, L. (2010) Trends in property and illicit drugcrime around the Medically Supervised Injecting Centre in Kings Cross: anupdate. NSW Bureau of Crime Bureau Statistics and Research, 51, 1-6

  16. Freeman, K., Jones, C., Weatherburn, D., Rutter, S., Spooner, C. y Donnelly, N. (2005).The impact of the Sydney Medically Supervised Injecting Centre (MSIC) oncrime. Australian Professional Society on Alcohol and Other Drugs, 24, 173-184.https://doi.org/10.1080/09595230500167460

  17. Fry, C. L. (2002). Injecting drug user attitudes towards rules for supervised injectingrooms: implications for uptake. International Journal of Drug Policy, 13(6), 471-476. https://doi.org/10.1016/S0955-3959(02)00076-2

  18. Gagnon, M. (2017). It’s time to allow assisted injection in supervised injection sites.Canadian Medical Association Journal, 189(34), E1083-E1084.https://doi.org/10.1503/cmaj.170659

  19. Gostin, L. O., Hodge, J. G., y Gulinson, C. L. (2019). Supervised Injection Facilities.JAMA, 321(8), 745. https://doi.org/10.1001/jama.2019.0095

  20. Hadland, S. E., Debeck, K., Kerr, T., Nguyen, P., Dobrer, S., Montaner, J. S., y Wood,E. (2014). Use of a Medically Supervised Injection Facility Among Drug-InjectingStreet Youth. Journal of Adolescent Health, 54(2), S88-S89.https://doi.org/10.1016/j.jadohealth.2013.10.189

  21. Harris, R. E., Richardson, J., Frasso, R., y Anderson, E. D. (2018). Perceptions aboutsupervised injection facilities among people who inject drugs in Philadelphia.International Journal of Drug Policy, 52, 56-61.https://doi.org/10.1016/j.drugpo.2017.11.005

  22. Hood, J. E., Behrends, C. N., Irwin, A., Schackman, B. R., Chan, D., Hartfield, K., Hess,J., Banta-Green, C., Whiteside, L., Finegood, B. y Duchin, J. (2019). Theprojected costs and benefits of a supervised injection facility in Seattle, WA, USA.International Journal of Drug Policy, 67, 9-18.https://doi.org/10.1016/j.drugpo.2018.12.015

  23. Hyshka, E., Bubela, T. y Wild, T. (2013). Prospects for scaling-up supervised injectionfacilities in Canada: the role of evidence in legal andpolitical decision-making.Society for the study of Addiction, 108, 468-476.https://doi.org/10.1111/add.12064

  24. Jozaghi, E. (2012). Science versus politics: The need for supervised injection facilities inMontreal, Canada. International Journal of Drug Policy, 23(5), 420–421.https://doi.org/10.1016/j.drugpo.2012.06.003

  25. Jozaghi, E. (2013). “The biggest mistake God ever made was to create junkies”: Unsafeinjection practices, health care discrimination and overdose deaths in Montreal,Canada. Canadian Graduate Journal of Sociology and Criminology, 2(1), 20.https://doi.org/10.15353/cgjsc-rcessc.v2i1.16

  26. Jozaghi, E., y Jackson, A. (2015). Examining the potential role of a supervised injectionfacility in Saskatoon, Saskatchewan, to avert HIV among people who injectdrugs. International Journal of Health Policy and Management, 4(6), 373-379.https://doi.org/10.15171/ijhpm.2015.73

  27. Jozaghi, E., y Reid, A. A. (2014). A Case Study of the Transformative Effect of PeerInjection Drug Users in the Downtown Eastside of Vancouver, Canada. CanadianJournal of Criminology and Criminal Justice, 56(5), 563-594.https://doi.org/10.3138/cjccj.2013.e30

  28. Jozaghi, E., Reid, A. A., Andresen, M. A., y Juneau, A. (2014). A cost-benefit/costeffectivenessanalysis of proposed supervised injection facilities in Ottawa,Canada. Substance Abuse Treatment, Prevention, and Policy, 9(1).https://doi.org/10.1186/1747-597x-9-31

  29. Karamouzian, M., Dohoo, C., Forsting, S., McNeil, R., Kerr, T., y Lysyshyn, M. (2018).Evaluation of a fentanyl drug checking service for clients of a supervised injectionfacility, Vancouver, Canada. Harm Reduction Journal, 15(1).https://doi.org/10.1186/s12954-018-0252-8

  30. Kennedy, M. C., Boyd, J., Mayer, S., Collins, A., Kerr, T., y McNeil, R. (2019). Peerworker involvement in low-threshold supervised consumption facilities in thecontext of an overdose epidemic in Vancouver, Canada. Social Science yMedicine, 225, 60-68. https://doi.org/10.1016/j.socscimed.2019.02.014

  31. Kennedy, M. C., Karamouzian, M., y Kerr, T. (2017). Public Health and Public OrderOutcomes Associated with Supervised Drug Consumption Facilities: aSystematic Review. Current HIV/AIDS Reports, 14(5), 161-183.https://doi.org/10.1007/s11904-017-0363-y

  32. Kerr, T. (2005). A Description of a Peer-Run Supervised Injection Site for Injection DrugUsers. Journal of Urban Health: Bulletin of the New York Academy of Medicine,82(2), 267-275. https://doi.org/10.1093/jurban/jti050

  33. Kerr, T., Small, W., Moore, D., y Wood, E. (2007). A micro-environmental intervention toreduce the harms associated with drug-related overdose: evidence from theevaluation of Vancouver's safer injection facility. International Journal of DrugPolicy, 18(1), 37-45. https://doi.org/10.1016/j.drugpo.2006.12.008

  34. Kerr, T., Tyndall, M. W., Lai, C., Montaner, J. S. G., y Wood, E. (2006). Drug-relatedoverdoses within a medically supervised safer injection facility. InternationalJournal of Drug Policy, 17(5), 436-441.https://doi.org/10.1016/j.drugpo.2006.05.008

  35. Kimber, J., Mattick, R., Kaldor, J., van Beek, I., Gilmour, S., y Rance, J. (2008). Processand predictors of drug treatment referral and referral uptake at the SydneyMedically Supervised Injecting Centre. Drug and Alcohol Review, 27(6), 602-612.https://doi.org/10.1080/09595230801995668

  36. Kinnard, E. N., Howe, C. J., Kerr, T., Skjødt Hass, V., y Marshall, B. D. (2014). Selfreportedchanges in drug use behaviors and syringe disposal methods followingthe opening of a supervised injecting facility in Copenhagen, Denmark. HarmReduction Journal, 11(1), 29. https://doi.org/10.1186/1477-7517-11-29

  37. Kolla, G., Strike, C., Watson, T. M., Jairam, J., Fischer, B., y Bayoumi, A. M. (2017).Risk creating and risk reducing: Community perceptions ofsupervisedconsumption facilities for illicit drug use. Health, Risk y Society, 19(1-2), 91-111. https://doi.org/10.1080/13698575.2017.1291918

  38. Kral, A., Wenger, L., Carpenter, L., Wood, E., Kerr, T. y Bourgois, P. (2010).Acceptability of a Safer Injection Facility among Injection Drug Users in SanFrancisco. National Institute of Help, 110(1-2), 160-163.https://doi.org/10.1016/j.drugalcdep.2010.02.009

  39. Lange, B. C. L., y Bach-Mortensen, A. M. (2019). A systematic review of stakeholderperceptions of supervised injection facilities. Drug and Alcohol Dependence, 197,299-314. https://doi.org/10.1016/j.drugalcdep.2019.02.006

  40. Lloyd Smith, E., Wood, E., Zhang, R., Tyndall, M. W., Montaner, J. S., y Kerr, T. (2009).Determinants of Cutaneous Injection-Related Infection Care at a SupervisedInjecting Facility. Annals of Epidemiology, 19(6), 404–409.https://doi.org/10.1016/j.annepidem.2009.03.007

  41. Lloyd-Smith, E., Wood, E., Zhang, R., Tyndall, M. W., Montaner, J. S., y Kerr, T. (2008).Risk factors for developing a cutaneous injection-related infection amonginjection drug users: a cohort study. BMC Public Health, 8(1).https://doi.org/10.1186/1471-2458-8-405

  42. Lloyd-Smith, E., Wood, E., Zhang, R., Tyndall, M. W., Sheps, S., Montaner, J. S., yKerr, T. (2010). Determinants of hospitalization for a cutaneous injection-relatedinfection among injection drug users: a cohort study. BMC Public Health, 10(1).https://doi.org/10.1186/1471-2458-10-327

  43. MacArthur, G. J., van Velzen, E., Palmateer, N., Kimber, J., Pharris, A., Hope, V.,Taylor, A., Roy, K., Aspinall, E., Goldberg, D., Rhodes, T., Hedrich, D., Salminen,M., Hickman, M. y Hutchinson, S. J. (2014). Interventions to prevent HIV andHepatitis C in people who inject drugs: A review of reviews to assess evidence ofeffectiveness. International Journal of Drug Policy, 25(1), 34-52.https://doi.org/10.1016/j.drugpo.2013.07.001

  44. Madah-Amiri, D., Skulberg, A. K., Braarud, A.-C., Dale, O., Heyerdahl, F., Lobmaier, P.,y Clausen, T. (2018). Ambulance-attended opioid overdoses: An examination intooverdose locations and the role of a safe injection facility. Substance Abuse, 1-6.https://doi.org/10.1080/08897077.2018.1485130

  45. Marshall, B. D., Milloy, M. J., Wood, E., Montaner, J. S., y Kerr, T. (2011). Reduction inoverdose mortality after the opening of North America's first medically supervisedsafer injecting facility: a retrospective population-based study. The Lancet,377(9775), 1429-1437. https://doi.org/10.1016/S0140-6736(10)62353-7

  46. McNeil, R., Small, W., Lampkin, H., Shannon, K., y Kerr, T. (2014). “People Knew TheyCould Come Here to Get Help”: An Ethnographic Study of Assisted InjectionPractices at a Peer-Run “Unsanctioned” Supervised Drug Consumption Room ina Canadian Setting. AIDS and Behavior, 18(3), 473–485.https://doi.org/10.1007/s10461-013-0540-y

  47. Norma Oficial Mexicana NOM-028-SSA2-2009 Para la prevención, tratamiento y controlde las adicciones (2009).http://www.conadic.salud.gob.mx/pdfs/norma_oficial_nom.pdf

  48. Potier, C., Laprévote, V., Dubois-Arber, F., Cottencin, O., y Rolland, B. (2014).Supervised injection services: What has been demonstrated? A systematicliterature review. Drug and Alcohol Dependence, 145, 48-68.https://doi.org/10.1016/j.drugalcdep.2014.10.012

  49. Small, W., Shoveller, J., Moore, D., Tyndall, M., Wood, E., y Kerr, T. (2011). InjectionDrug Users’ Access to a Supervised Injection Facility in Vancouver, Canada: TheInfluence of Operating Policies and Local Drug Culture. Qualitative HealthResearch, 21(6), 743-756. https://doi.org/10.1177/1049732311400919

  50. Tizoc-Marquez, A., Rivera-Fierro, K., Rieke-Campoy, U., y Cruz-Palomares, M. (2017)Reducción de daños como estrategia para el uso y abuso de sustancias enMéxico: desafíos y oportunidades. Ra Ximhai, 13(2), 39-51

  51. Tweed, E. J., Rodgers, M., Priyadarshi, S., y Crighton, E. (2018). “Taking away thechaos”: a health needs assessment for people who inject drugs in public placesin Glasgow, Scotland. BMC Public Health, 18(1). https://doi.org/10.1186/s12889-018-5718-9

  52. Wood, R. A., Wood, E., Lai, C., Tyndall, M. W., Montaner, J. S., y Kerr, T. (2008).Nurse-delivered safer injection education among a cohort of injection drug users:Evidence from the evaluation of Vancouver's supervised injection facility.International Journal of Drug Policy, 19(3), 183-188




2020     |     www.medigraphic.com